QuantaBiotica
Natural health product licensed in Canada
- Licence holder
- Ultra Bio-Logics Inc.
- NPN or DIN-HM
- 80021729
- Status
- Inactive licence
- Licence date
- 14 October 2010
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lactobacillus acidophilus Source : HA-122 | 1 Milliards d'UFC | Not calculated |
| Lactobacillus salivarius Source : HA-118 | 1 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Fructo-oligosaccharides, Hypromellose, Acide ascorbique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | Not specified |
| Enfants | minimum: 1 year | 1 Capsule | Not specified |
| Enfants | minimum: 1 year | 3 Capsule | Not specified |
| Adultes | Not specified | 3 Capsule | Not specified |
Uses authorised in Canada
Allégation 1 : Contribue à une flore intestinale naturelle en santé. Allégation 2 : Pour aider à traiter la diarrhée infectieuse aiguë.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Ne pas utiliser si vous souffrez de nausées, de la fièvre, de vomissements, de diarrhée sanglante ou de douleurs abdominales intenses. Ne pas utiliser si vous souffrez d'un déficit immunitaire (e.g. sida, lymphome, patients subissant un traitement prolongé aux corticostéroïdes).
Source
Official Health Canada record, licence 80021729
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.